BW

04

Ene

By MetroLatinoUSA

BW

Arugula Sciences Announces Company Launch with FDA Phase 1 Approval for Osteoarthritis Therapy

Company Pipeline Includes Drugs to Treat Chronic Inflammation and Degenerative Diseases IRVING, Texas--(BUSINESS WIRE)--Arugula Sciences, LLC. today announced that it has, in collaboration with its clinical partners, advanced its first therapeutic product, Signature Cord Prime™ (SIG001), with FDA approval for a Phase 1 clinical trial (NCT05234489) in the US. This…

Leer más...

04

Ene

By MetroLatinoUSA

BW

Intrauterine Insemination (IUI) Success can be Predicted with a New IUI Assessment Released by Posterity Health and Path Fertility

DENVER--(BUSINESS WIRE)--Posterity Health, the only virtual Male Fertility Center of Excellence that offers personalized care, educational resources, and effective treatments to address male fertility, joins forces with Path Fertility, the creators of SpermQT, an epigenetic sperm quality test that can predict fertility outcomes not detected in a standard semen analysis.…

Leer más...

04

Ene

By MetroLatinoUSA

BW

Blackboxstocks Extends Stock Buyback Program Through 2023

DALLAS--(BUSINESS WIRE)--Blackboxstocks Inc. (NASDAQ: BLBX), (“Blackbox” or the “Company”), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders of all levels, announced today that it has extended its $2.5 million stock buyback program to December 31, 2023. The buyback program was initiated…

Leer más...

04

Ene

By MetroLatinoUSA

BW

ADC Therapeutics to Participate in the 41st Annual J.P. Morgan Healthcare Conference

LAUSANNE, Switzerland--(BUSINESS WIRE)--ADC Therapeutics SA (NYSE: ADCT) announced today that Ameet Mallik, Chief Executive Officer, will present a company overview at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on Wednesday, January 11th at 3:00 p.m. PT. A live webcast of the presentation will be available via…

Leer más...

04

Ene

By MetroLatinoUSA

BW

BWXT Promotes Chip Whitford to Senior Vice President and General Counsel

LYNCHBURG, Va.--(BUSINESS WIRE)--$BWXT--BWX Technologies, Inc. (NYSE: BWXT) has promoted Ronald O. (Chip) Whitford, Jr. to the position of senior vice president, general counsel, chief compliance officer and corporate secretary, effective January 2, 2023. Whitford is succeeding Thomas E. McCabe, who will serve as special advisor to the CEO until his…

Leer más...

04

Ene

By MetroLatinoUSA

BW

Safety Vision Announces SafetyNET 5™ Video Management Software

HOUSTON--(BUSINESS WIRE)--#ADAS--Safety Vision, LLC announces SafetyNET 5™ (SN 5™) VMS, a new generation platform for fleet video management. An alternative to existing video management software, SN 5™ is built from the ground up allowing us to deliver the highest level of security while providing the ability to add or enhance…

Leer más...

04

Ene

By MetroLatinoUSA

BW

BeiGene to Present at the J.P. Morgan 41st Annual Healthcare Conference

CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING--(BUSINESS WIRE)--$bgne #beigene--BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company today announced that the Company will participate in the J.P. Morgan 41st Annual Healthcare Conference on Monday, January 9, 2023 at 1:30 p.m. PT. A live webcast can be accessed from…

Leer más...

04

Ene

By MetroLatinoUSA

BW

Ares Capital Corporation Schedules Earnings Release for the Fourth Quarter and Fiscal Year Ended December 31, 2022

NEW YORK--(BUSINESS WIRE)--Ares Capital Corporation (“Ares Capital”) (NASDAQ: ARCC) announced today that it will report earnings for the fourth quarter and fiscal year ended December 31, 2022 on Tuesday, February 7, 2023 prior to the opening of the Nasdaq Global Select Market. Ares Capital invites all interested persons to attend…

Leer más...

04

Ene

By MetroLatinoUSA

BW

Bicycle Therapeutics Announces FDA Fast Track Designation Granted to BT8009 for the Treatment of Adult Patients with Previously Treated Locally Advanced or Metastatic Urothelial Cancer

CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that the United States Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to Bicycle’s BT8009 monotherapy for the…

Leer más...

04

Ene

By MetroLatinoUSA

BW

Seres Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that Seres management will present at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023, at 8:15 a.m. PST / 11:15 a.m. EST. An audio webcast of the presentation will be available under…

Leer más...